Antipodes Partners’s Northrop Grumman NOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-85,744
Closed -$39.6M 76
2023
Q1
$39.6M Sell
85,744
-124,073
-59% -$57.6M 1.37% 29
2022
Q4
$114M Sell
209,817
-84,522
-29% -$44.1M 4.11% 6
2022
Q3
$138M Buy
294,339
+98,457
+50% +$46.9M 5.56% 4
2022
Q2
$93.7M Sell
195,882
-46,281
-19% -$21.3M 3.9% 9
2022
Q1
$108M Buy
+242,163
New +$100M 3.84% 11

Other funds holding NOC

Antipodes Partners's NOC Position: Q2 2023 in Review

Antipodes Partners sold out of Northrop Grumman (NOC) in Q2 2023, closing a stake of 85,744 shares — an estimated $39.6M sold.

Antipodes Partners first reported a position in NOC in Q1 2022 and held it in 5 quarters. The position peaked at $138M in Q3 2022. 1,411 funds tracked by Wall St. Rank hold NOC as of Q2 2023.

  • Antipodes Partners reported no remaining Northrop Grumman position as of Q2 2023 after selling out during the quarter.
  • Antipodes Partners sold 85,744 Northrop Grumman shares in Q2 2023, an estimated $39.6M.
  • Antipodes Partners first reported a position in Northrop Grumman in Q1 2022 and held it in 5 quarters.
  • Antipodes Partners's Northrop Grumman position peaked at $138M in Q3 2022.
  • 1,411 funds tracked by Wall St. Rank held Northrop Grumman as of Q2 2023.

Based on Antipodes Partners's 13F filing for Q2 2023, filed 25 Jul 2023.